Examkin

Soru

Zorluk: KolayResearch Ethics and Conflicts of Interest

A 45-year-old physician is the principal investigator for a randomized controlled trial evaluating a novel oral anticoagulant. The study is fully sponsored by the pharmaceutical company that manufactures the medication. During a planning meeting, the pharmaceutical representative offers the physician a $500 "finder's fee" for each patient successfully enrolled and randomized in the trial. This fee is offered in addition to the standard fair-market compensation for the investigator's time, effort, and research-related administrative expenses. The representative explains that this bonus is intended to accelerate the recruitment process. Which of the following is the most appropriate response by the physician?

  1. Decline the fee because it constitutes an unethical conflict of interest that may incentivize inappropriate patient enrollment.Cevap
  2. B
    Accept the fee, provided that patient confidentiality is strictly maintained when reporting the enrolled participants to the sponsor.
  3. C
    Accept the fee, as long as potential bias and confounding are explicitly addressed in the final statistical analysis.
  4. D
    Accept the fee only if the study design is an observational cohort study rather than an interventional clinical trial.
  5. E
    Accept the fee, provided the research team agrees to perform a root cause analysis if any patient safety incidents occur during the trial.

Cevap

Decline the fee because it constitutes an unethical conflict of interest that may incentivize inappropriate patient enrollment.
The correct response is to decline the fee. According to the AMA Code of Medical Ethics and standard institutional review board (IRB) policies, physicians should not accept payment solely for referring or enrolling patients in research studies (commonly known as 'finder's fees'). Such payments create a severe financial conflict of interest. They introduce a strong incentive for investigators to recruit patients who might not be appropriate candidates for the study or to subtly coerce patients into participating, thereby undermining the integrity of the informed consent process and jeopardizing patient safety. While it is completely ethical for investigators to receive fair-market compensation for their actual time, effort, and administrative expenses related to conducting the research, bonuses tied strictly to enrollment numbers are unethical and must be refused.

Adım Adım Çözüm

1
Identify the ethical dilemma presented in the scenario.
A pharmaceutical sponsor is offering a 'finder's fee' (a per-capita bonus for patient enrollment) to a principal investigator.
Recognizing the nature of the financial offer is the first step in applying research ethics guidelines.
2
Apply the principles of research ethics regarding conflicts of interest.
Finder's fees create a direct financial incentive to recruit patients, which may lead to coercing vulnerable patients or enrolling individuals who do not strictly meet inclusion criteria.
The primary goal of research ethics is to protect subjects from harm and ensure voluntary, uncoerced informed consent.
3
Determine the most appropriate action for the physician.
The physician must decline the finder's fee to maintain professional integrity and protect patient welfare.
Standard fair-market compensation for time and effort is acceptable, but per-capita enrollment bonuses are explicitly prohibited by medical ethics codes.

Anahtar Kavram

Finder's fees (payment solely for enrolling patients in research) are unethical because they create a financial conflict of interest that can compromise patient safety and informed consent.
Bu soruyu puanla

Konular

Research Ethics and Conflicts of Interest

Bu konudan daha fazla soru